Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
Luis Oliverio Ambriz Garcia, Doctor, Specialist in Internal Medicine at HRAEB, Chief Executive Officer of Memodi, shared a post on X about a recent article by Jacquelyn M. Powers et al., published in Blood Advances, adding:
“Latest ASH guidelines (2026) on iron deficiency.
Key points:
- Adult: ferritin 30 ng/mL or less, deficiency. Sensitivity 67%, specificity 96%. The threshold applies even without anemia; the diagnosis does not depend on hemoglobin.
- With symptoms or persistent risk factor, the cutoff rises to 50 ng/mL or less. The cost is more false positives, so it’s best to use it in those with a real pretest probability.
- Inflammation: ferritin plus TSAT, never ferritin alone. Applies in heart failure, CKD, IBD, cancer, and rheumatic disease. Diagnosis is considered with TSAT less than 20% or ferritin less than 100 ng/mL. TSAT should be taken after fasting for 5 to 9 hours and without iron supplements.
- The lab’s ‘normal range’ is a problem. The lower limits for ferritin were set with a ‘seemingly healthy’ population that included people with deficiency. A ferritin of 18 marked as ‘normal’ on the report is still deficiency.
I’m going to finish reading them thoroughly to update the apps.”
Title: American Society of Hematology 2026 guidelines for diagnosis of iron deficiency
Authors: Jacquelyn M Powers, Ming Yeong Lim, Maureen O. Achebe, Imo J Akpan, Michael Auerbach, Megan C Brown, Maria Paula Cardenas, Caroline Cromwell, Thomas G. DeLoughery, Robert E. Fleming, Martina Fraga, George Goshua, Paula D. James, Adam K Lewkowitz, Jori Ellen May, Grace Nnadozie, Frances Ogunnaya, Guillermo J. Ruiz-Arguelles, Michelle Sholzberg, Layla Van Doren, Angela C. Weyand, Michelle Paula Zeller, Muayad Azzam, Ali Choaib, Qais Hamarsha, Hassan Kawtharany, Jana Khawandi, Reem A. Mustafa
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points
-
Sep 19, 2026, 01:23Chokri Ben Lamine: Cemdisiran in PNH – Why Combine Complement Therapies?
-
Sep 19, 2026, 01:19Stefano Garzon: Comparing DOACs SAPT and DAPT After LAAO
-
Sep 19, 2026, 01:18Elad Asher: What Should a Patient Take after Left Atrial Appendage Occlusion?
-
Sep 19, 2026, 00:48Mahmoud Mehawed: Heparin vs Warfarin vs DOACs Understanding the Key Differences
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss